HCV genotype 6a escape from and resistance to velpatasvir, pibrentasvir, and sofosbuvir in robust infectious cell culture models
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME trial
Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin diabetes control and potential adverse events
The reassuring news is that having had your gallbladder removed does not automatically preclude you from using weight loss injections, though certain considerations warrant careful discussion with your healthcare provider
Whilst modest weight fluctuations are normal during Ozempic treatment, certain situations warrant prompt medical review
Some report an increase in energy, confidence, and even sexual desire as they lose weight